Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 6

Research Article

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 6

Blood lipid levels of the two groups whose Lipitor medication time 20% of the 6-month treatment.

C-117 formula group (n=44) Placebo group (n=42) Z/TP

Triglyceride (mmol/L)

Before treatment1.33 ± 0.581.56 ± 0.90
After treatment1.25 ± 0.531.27 ± 0.56-0.4300.966

Total cholesterol (mmol/L)

Before treatment5.02 ± 0.945.01 ± 0.78
After treatment4.62 ± 0.964.74 ± 0.85-0.5670.572

Low-density lipoprotein (mmol/L)

Before treatment3.09 ± 0.813.13 ± 0.78
After treatment2.86 ± 0.793.04 ± 0.72-1.1160.267

M, mean ± standard deviation. P is the P value of the FAS dataset;
P<0.05 vs. before treatment.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.